Issued Patents All Time
Showing 1–25 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12292451 | ApoA1 exchange rate assays in serum | Jonathan Smith, Shuhui Wang Lorkowski | 2025-05-06 |
| 12092648 | Detection of glucuronidated and 3-bromotyrosine | Zeneng Wang | 2024-09-17 |
| 12055535 | Trimethylamine compounds as risk predictors of cardiovascular disease | Zeneng Wang, Bruce S. Levison | 2024-08-06 |
| 11911399 | Treating and preventing disease with TMA and TMAO lowering agents | — | 2024-02-27 |
| 11835503 | TMA-formation inhibitor treatment for elevated TMA-containing compound diseases | Zeneng Wang, Bruce S. Levison | 2023-12-05 |
| 11782002 | NMR quantification of TMAO | James D. Otvos, Elias J. Jeyarajah, Justyna E. Wolak-Dinsmore, Thomas M. O'Connell, Dennis W. Bennett +1 more | 2023-10-10 |
| 11771659 | Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway | Jonathan Brown | 2023-10-03 |
| 11331280 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, Jodie Michelle Reed, Lori Ann Reinsalu, Vincent Peter Sica, Timothy Robert Baker | 2022-05-17 |
| 11249091 | Detection of glucuronidated and 3-bromotyrosine | Zeneng Wang | 2022-02-15 |
| 11246844 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, Xiaodong Gu, Michael Reilly +3 more | 2022-02-15 |
| 10983100 | Trimethylamine-containing compounds for diagnosis and prediction of disease | Zeneng Wang, Bruce S. Levison | 2021-04-20 |
| 10933072 | Treating and preventing disease with TMA and TMAO lowering agents | — | 2021-03-02 |
| 10849866 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, Xiaodong Gu | 2020-12-01 |
| 10786479 | Methods for inhibiting conversion of carnitine to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin +4 more | 2020-09-29 |
| 10780072 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin +4 more | 2020-09-22 |
| 10751301 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, Michael Reilly, Xiaodong Gu | 2020-08-25 |
| 10675256 | Methods for inhibiting conversion of choline to trimethylamine (TMA) | Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, Xiaodong Gu | 2020-06-09 |
| 10613044 | NMR quantification of TMAO | James D. Otvos, Elias J. Jeyarajah, Justyna E. Wolak-Dinsmore, Thomas M. O'Connell, Dennis W. Bennett +1 more | 2020-04-07 |
| 10551372 | Trimethylamine compounds as risk predictors of cardiovascular disease | Zeneng Wang, Bruce S. Levison | 2020-02-04 |
| 10241093 | Trimethylamine-containing compounds for diagnosis and prediction of disease | Zeneng Wang, Bruce S. Levison | 2019-03-26 |
| 10213407 | Compounds and methods for inhibiting production of trimethylamine | Jose Carlos Garcia-Garcia, John August Wos | 2019-02-26 |
| 10117879 | Treating and preventing disease with TMA and TMAO lowering agents | — | 2018-11-06 |
| 10064830 | Treatment and prevention of cardiovascular disease and thrombosis | Bruce S. Levison, Zeneng Wang | 2018-09-04 |
| 9694020 | Treating and preventing disease with TMA and TMAO lowering agents | — | 2017-07-04 |
| 9612242 | Combined F2-isoprostane and myleoperoxidase detection, a risk indicator for cardiovascular disease | Renliang Zhang | 2017-04-04 |